Versiti Blood Research Institute recently integrated its Hematopoiesis and Immunology research programs to drive scientific progress.
Hematopoiesis and Immunology Research Program
The Versiti Blood Research Institute (VBRI) has a legacy of advancing immunobiology and hematopoiesis, two interconnected fields essential for understanding blood cell development, leukemia, and immune cell function and dysregulation.
Early VBRI research on antibody/antigen recognition improved blood transfusion safety, led to the first allogeneic bone marrow transplant-a critical treatment for leukemia, and established the National Marrow Donor Program, benefiting patients in Milwaukee and around the world.
Today, investigators use cutting-edge technologies to study bone marrow function and leukemia, lymphocyte development, and immune deficiencies and autoimmune diseases. These efforts uncover insights into blood disorders, immune dysfunction, and hematologic malignancies, advancing innovative therapies.
VBRI remains committed to driving basic science that bridges immunology and hematopoiesis to improve treatments for blood and immune-related diseases.
Browse our Investigators, Emeritus Investigators, and other members of the Blood Research Institute.
Scientific Programs
Scientific research and training are important parts of Versiti’s mission. Our research programs involve basic and clinical scientists at Versiti Blood Research Institute.
Funding Research
Versiti Blood Research Institute Foundation accepts financial and philanthropic gifts from donors, which helps to propel lifesaving research.
Versiti Blood Research Institute
Versiti Blood Research Institute investigators study blood disorders like hemophilia, blood cancers like leukemia, and other blood diseases.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking ACCEPT, you consent to the use of all the cookies.
